Clinical Trials Directory

Trials / Completed

CompletedNCT00163176

Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tumor cell proliferation and repopulation contribute to resistance to radiotherapy in head and neck cancer. Up to now, this characteristic is mostly assessed using biopsies acquired during inspection under general anaesthesia before treatment. 18F-FLT-PET (positron emission tomography) is a non-invasive imaging method showing areas of active proliferation. The aim of this study is to assess the value of the functional information gained by 18F-FLT-PET for radiotherapy planning and early tumor response assessment. Prior to radiotherapy, a planning CT-scan and a 18F-FLT-PET scan are acquired. After approximately two weeks of radiotherapy a further PET scan is obtained.

Conditions

Timeline

Start date
2005-07-01
Primary completion
2008-12-01
Completion
2010-12-01
First posted
2005-09-13
Last updated
2011-12-16

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00163176. Inclusion in this directory is not an endorsement.

Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors (NCT00163176) · Clinical Trials Directory